Dan Peisert, Assertio president and CEO
From CRL to buyout in five months: Assertio to acquire Spectrum in $248M stock deal
Specialty pharmaceuticals company Assertio Holdings will buy Spectrum Pharmaceuticals in an all-stock deal for about $248 million, the companies said Tuesday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.